Eli Lilly completed its acquisition of ICOS Corp for $23 billion
On Jan. 29, 2007, Eli Lilly announced it had completed its acqusition of ICOS Corp. for $2.3 billion…
Phase III clinical trial showed patients treated with arsenic trioxide had better overall survival than patients who received chemotherapy alone
On Jan. 23, 2007, results from a large phase III clinical trial show that adult patients with previously…
FDA licensed the refrigerator formulation of FluMist
On Jan. 9, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved a refrigerated form…
Human infection with a novel influenza virus was added to the nationally notifiable disease list
On Jan. 9, 2007, the Executive Committee of the Council of State and Territorial Epidemiologists approved an interim…
Virginia Tech Carilion School of Medicine and Research Institute was founded
On Jan. 3, 2007, Virginia Tech President Charles W. Steger, then Carilion Clinic President and CEO Edward G….
Sirna Therapeutics was acquired by Merck for $11 billion in cash
On Jan.2, 2007, Merck announced that it had completed its acquisition of Sirna Therapeutics for $1.1 billion in…
Genome sequencing of the horse was completed
In Jan. 2007, the sequencing of the horse genome project was completed. The initial goal of the Horse…
Biotechnology | Chemical | Diagnostics | Infectious Disease | Life Science News | Medicine | Therapeutics | Vaccine
Livermore Lab developed pathogen signatures for bioterrorist attack Identification
In 2007, researchers at Livermore National Laboratory announced they had developed candidate signatures for pathogens that might be…
Yale’s West Campus, located on 136 acres 7 miles west of downtown New Haven, was acquired
In 2007, West Campus, located on 136 acres 7 miles west of downtown New Haven, was acquired. West…
Lethal infection of K18-hACE2 mice infected with Severe Acute Respiratory Syndrome Coronavirus published
In January 2007, scientists at the University of Iowa reported in the Journal of Virology that they had…
The Massachusetts Life Sciences Center (MLSC) was formed
In 2007, the Massachusetts Life Sciences Center (MLSC) was formed as an economic development and investment agency dedicated…
Rheumatoid Arthritis gene was discovered
On Nov. 8, 2007, researchers from Brigham and Women’s and MIT’s Broad Institute and Harvard discovered a gene…
FDA approved Elelyso (taliglucerase alfa) for long-term enzyme replacement therapy to treat a form of Gaucher disease
In 2007, the U.S. Food and Drug Administration (FDA) approved Elelyso (taliglucerase alfa) for long-term enzyme replacement therapy…
Nancy Wexler, PhD, received the Benjamin Franklin Medal in Life Science for her discovery of the gene for Huntington’s Disease
In 2007, Nancy Wexler, PhD, received the Benjamin Franklin Medal in Life Science for her discovery of the…
Jordan Tang led a team of OMRF scientists that identified and cloned the enzyme believed to cause Alzheimer’s disease
In 2007, Dr. Jordan Tang, led a team of scientists at Oklahoma Medical Research Foundation (OMRF) that identified…
The Oregon Translational Research and Drug Discovery Institute at Oregon State University was founded
In 2007, The Oregon Translational Research and Drug Discovery Institute (OTRADI) at Oregon State University was established by…
Biotechnology | Life Science News | Medical Device | Neurology | Non-Profit Research | Pharmaceutical | Therapeutics
Vanderbilt Center for Neuroscience Drug Discovery was founded
In 2007, the Vanderbilt Center for Neuroscience Drug Discovery was established, combining the expertise of four groups of…
The Cancer Prevention and Research Institute of Texas was founded
In 2007, Texas voters overwhelmingly approved a constitutional amendment that established the Cancer Prevention and Research Institute of…
Texas Biomed geneticists announced discovery that a particular gene, VNN1, plays a major role in the regulation of HDL cholesterol levels
In 2007, Texas Biomed geneticists announced their discovery that a particular gene, VNN1, plays a major role in…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Non-Profit Research | Therapeutics
The Center for Clinical and Translational Research was founded at Virginia Commonwealth University
In 2007, the Center for Clinical and Translational Research (CCTR) was founded at Virginia Commonwealth University to enhance…
R Paul Robertson received two NIDDK grants totaling to improve islet transplantation
In 2007, R. Paul Robertson, M.D., at the Pacific Northwest Research Institute, received two grants totaling $3,173,400 from…
Cocrystal Discovery (Cocrystal Pharma) was founded
In 2007, Cocrystal Discovery, now known as Cocrystal Pharma, was founded in Bothell as a pharmaceutical company with…
Jubilant Organosys acquired Hollister-Stier
On Apr. 25, 2007, Jubilant Organosys, Ltd. announced it had acquired Spokane-based Hollister-Stier for $122.5 million. The plant…
The CDC responded to a multi-state outbreak of E coli infections
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
The Animal Enterprise Terrorism Act was signed into lawﾠ
On Nov. 27, 2006, the Animal Enterprise Terrorism Act (AETA) was officially signed into law by President George…
Biotechnology | Diagnostics | Genomics | Life Science News | NIH | Non-Profit Research | Therapeutics | U.S. Congress
Washington University received its largest grant ever for the Genome Sequencing Center
On Nov. 20, 2006, the Genome Sequencing Center at Washington University School of Medicine in St. Louis announced…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Therapeutics | Women's Health
FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
The National Cancer Institute released preliminary data on genetic susceptibility for prostate cancer
On Oct. 19, 2006, the National Cancer Institute released new data from the Cancer Genetic Markers of Susceptibility…
The FDA approved Gleevec for Five Rare, Life-Threatening Disorders
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) approved the drug, Gleevec developed by Oregon…
ICOS Corp announced agreement to be acquired by Eli Lilly and Company
On Oct. 18, 2006, ICOS announced it had signed an agreement to be acquired by Eli Lilly and…